-
Hyderabad: Research by ReaGene Innovations Private Limited, a startup incubated at the ASPIRE-BioNEST, and INDRAS Private Limited suggests that an anti-diabetic drug Ertugliflozin, can be repurposed to treat Covid-19. According to the findings, the repurposed drug binds effectively to the receptor binding domain of the spike protein of Covid-19 and also displayed significant anti-inflammatory and […]
-
The seasonally-adjusted IHS Markit India Manufacturing Purchasing Managers' Index (PMI) declined to 48.1 in June from 50.8 in May.
-
The detailed time-tables for the examination have been made available on the website https://www.osmania.ac.in.
-
Out of 90,574 samples collected, 3,841 were found positive during the period, taking the total number of active cases to 38,178
-
With the delta variant, a study by British researchers found people were well protected when they got both doses of either the AstraZeneca or Pfizer-BioNTech vaccines.
-
Noting that the virus is new and is mutating, the prime minister said India's doctors, with their knowledge and experience, are fighting the challenges posed by the virus.
-
The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes.
-
According to Indian Oil Corporation Limited (IOCL), the largest supplier of ATF in the country, on Thursday reported price hiked by 3.6 per cent in the Delhi region.
-
India has already asked the EU member countries to individually consider allowing Indians who have taken Covishield and Covaxin vaccines and want to travel to Europe.
-
He called for celebrating the National Doctor's Day as a tribute to the dedication of doctors.
-
Following the first two waves where there has been an increase in infections amongst the younger population, child-specific needs are the focus of this new initiative called 'Breath of Life'.
-
On June 30, India recorded 817 fatalities due to the coronavirus, lowest since April 10. The death figures have crossed 1,000 mark once again after three days.
-
In its latest update on Thursday morning, the University's Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and death toll stood at 182,136,238 and 3,945,551, respectively.
-
The finance minister provided Rs 23,220 crore of additional funding to set up children and pediatric care at hospitals to prepare healthcare infrastructure to deal with any emergency.
-
"Like I always say #weareinthistogether. I am going to be safe not just for myself but for YOU as well. Fully vaccinated," she wrote.
-
Centre’s relief package may hold promise for the long term but what India needs is urgent measures to revive demand
-
Lockdowns have made people seek comfort in eating mostly junk food, exercise less, feel more anxious and sleep-deprived
-
For the shuttlers below 18 years of age, it will be made mandatory to carry a negative RT-PCR report with a barcode, 96 hours prior to departure from their respective stations.
-
On successful completion of the clinical trial, each company will independently approach the regulatory authorities for approval to manufacture and supply the drug for the treatment of Covid-19 in India
-
China earlier this month, authorised the emergency use of CoronaVac, for children aged between 3 and 17 years.